A role for MYB in direct control of the cell cycle via aberrant binding to B-MYB binding sites is possible given that MYB can compensate for loss of B-MYB in activation of Cyclin B1 expression in AML cells (49). This evidence concerns the gene MYBL2 and acute myeloid leukemia.